Skip to main content
. 2017 Jul 22;8(41):69906–69915. doi: 10.18632/oncotarget.19436

Figure 6.

Figure 6

(A) Viability of leukemia cells from patients with AZA resistance after treatment with 1 μM AZA and/or 1 μM teriflunomide (TFN) for 24 h. *p < 0.01. (B) Viability of healthy CD34+ cells after treatment with 1 μM AZA and/or 1 μM TFN for 48 h.